NEW YORK, Feb. 17, 2023 /PRNewswire/ -- The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Read the full report: https://www.reportlinker.com/p090599/?utm_source=PRN

Global Specialty Enzymes Market to Reach $13.6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Specialty Enzymes estimated at US$9.8 Billion in the year 2022, is projected to reach a revised size of US$13.6 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2022-2030. Protease, one of the segments analyzed in the report, is projected to record a 3.5% CAGR and reach US$2.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Carbohydrases segment is readjusted to a revised 3.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.7 Billion, While China is Forecast to Grow at 7% CAGR

The Specialty Enzymes market in the U.S. is estimated at US$2.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.4% and 4.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.8 Billion by the year 2030.

Select Competitors (Total 41 Featured)

- Advanced Enzymes Technologies Ltd.

- Amano Enzymes Inc.

- American Laboratories, Inc.

- Amicogen, Inc.

- BBI Solutions

- Biocatalysts Ltd.

- Codexis, Inc.

- Novozymes A/S

- Roche CustomBiotech

- Thermo Fisher Scientific, Inc.

Read the full report: https://www.reportlinker.com/p090599/?utm_source=PRN

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights

World Market Trajectories

Specialty Enzymes - Global Key Competitors Percentage Market

Share in 2022 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for

Players Worldwide in 2022 (E)

Impact of Covid-19 and a Looming Global Recession

Growing Demand for Eco-Friendly & Renewable Alternatives to

Chemical Catalysts Provides the Cornerstone for the Growth of

Biological Catalysts

Specialty Enzymes: Definition, Scope, Importance & Types

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Robust Demand for Medicines Spurs Opportunities for

Pharmaceutical Enzymes

Global Spending on Medicines (In US$ Billion) for Years 2018,

2020, 2022 and 2024

Robust Demand for Convenience Foods Drives Opportunities for

Specialty Enzymes in Food Processing

Global Convenience Food Industry (In US$ Million) for Years

2020, 2022, 2024 and 2026

Strong Demand for Dietary Protein Drives Opportunities for

Phytase Feed Enzymes in the Livestock Farming Industry

Global Per Capita Consumption of Livestock-Derived Protein (In

Kgs) by Country For Years 2020, 2025, 2030

Innovations in Microbial Enzymes

Growing Focus on Bioremediation Adds Growth Impetus to

Microbial Enzymes

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for

Specialty Enzymes by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Specialty Enzymes by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2014 through 2021 and % CAGR

Table 3: World 16-Year Perspective for Specialty Enzymes by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for

Protease by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for Protease by Geographic

Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2014 through 2021 and

% CAGR

Table 6: World 16-Year Perspective for Protease by Geographic

Region - Percentage Breakdown of Value Sales for USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for

Carbohydrases by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 8: World Historic Review for Carbohydrases by Geographic

Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2014 through 2021 and

% CAGR

Table 9: World 16-Year Perspective for Carbohydrases by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for

Polymerases & Nucleases by Geographic Region - USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for Polymerases & Nucleases by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Polymerases & Nucleases

by Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for

Lipase by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Lipase by Geographic Region -

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2014 through 2021 and

% CAGR

Table 15: World 16-Year Perspective for Lipase by Geographic

Region - Percentage Breakdown of Value Sales for USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for

Other Products by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2022 through 2030 and % CAGR

Table 17: World Historic Review for Other Products by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2014 through 2021 and % CAGR

Table 18: World 16-Year Perspective for Other Products by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for

Research & Biotechnology by Geographic Region - USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for Research & Biotechnology by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2014 through 2021 and % CAGR

Table 21: World 16-Year Perspective for Research &

Biotechnology by Geographic Region - Percentage Breakdown of

Value Sales for USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa for Years

2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for

Diagnostics by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 23: World Historic Review for Diagnostics by Geographic

Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2014 through 2021 and

% CAGR

Table 24: World 16-Year Perspective for Diagnostics by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2014, 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for

Pharmaceuticals by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2022 through 2030 and % CAGR

Table 26: World Historic Review for Pharmaceuticals by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2014 through 2021 and % CAGR

Table 27: World 16-Year Perspective for Pharmaceuticals by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2014, 2023 & 2030

Table 28: World Recent Past, Current & Future Analysis for

Other Applications by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2022 through 2030 and % CAGR

Table 29: World Historic Review for Other Applications by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2014 through 2021 and % CAGR

Table 30: World 16-Year Perspective for Other Applications by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2014, 2023 & 2030

Table 31: World Specialty Enzymes Market Analysis of Annual

Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES

Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial -

Key Competitors in the United States for 2023 (E)

Table 32: USA Recent Past, Current & Future Analysis for

Specialty Enzymes by Product - Protease, Carbohydrases,

Polymerases & Nucleases, Lipase and Other Products -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 33: USA Historic Review for Specialty Enzymes by Product -

Protease, Carbohydrases, Polymerases & Nucleases, Lipase and

Other Products Markets - Independent Analysis of Annual Sales

in US$ Million for Years 2014 through 2021 and % CAGR

Table 34: USA 16-Year Perspective for Specialty Enzymes by

Product - Percentage Breakdown of Value Sales for Protease,

Carbohydrases, Polymerases & Nucleases, Lipase and Other

Products for the Years 2014, 2023 & 2030

Table 35: USA Recent Past, Current & Future Analysis for

Specialty Enzymes by Application - Pharmaceuticals, Research &

Biotechnology, Diagnostics and Other Applications - Independent

Analysis of Annual Sales in US$ Million for the Years 2022

through 2030 and % CAGR

Table 36: USA Historic Review for Specialty Enzymes by

Application - Pharmaceuticals, Research & Biotechnology,

Diagnostics and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2014 through

2021 and % CAGR

Table 37: USA 16-Year Perspective for Specialty Enzymes by

Application - Percentage Breakdown of Value Sales for

Pharmaceuticals, Research & Biotechnology, Diagnostics and

Other Applications for the Years 2014, 2023 & 2030

CANADA

Table 38: Canada Recent Past, Current & Future Analysis for

Specialty Enzymes by Product - Protease, Carbohydrases,

Polymerases & Nucleases, Lipase and Other Products -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 39: Canada Historic Review for Specialty Enzymes by

Product - Protease, Carbohydrases, Polymerases & Nucleases,

Lipase and Other Products Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2014 through 2021 and %

CAGR

Table 40: Canada 16-Year Perspective for Specialty Enzymes by

Product - Percentage Breakdown of Value Sales for Protease,

Carbohydrases, Polymerases & Nucleases, Lipase and Other

Products for the Years 2014, 2023 & 2030

Table 41: Canada Recent Past, Current & Future Analysis for

Specialty Enzymes by Application - Pharmaceuticals, Research &

Biotechnology, Diagnostics and Other Applications - Independent

Analysis of Annual Sales in US$ Million for the Years 2022

through 2030 and % CAGR

Table 42: Canada Historic Review for Specialty Enzymes by

Application - Pharmaceuticals, Research & Biotechnology,

Diagnostics and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2014 through

2021 and % CAGR

Table 43: Canada 16-Year Perspective for Specialty Enzymes by

Application - Percentage Breakdown of Value Sales for

Pharmaceuticals, Research & Biotechnology, Diagnostics and

Other Applications for the Years 2014, 2023 & 2030

JAPAN

Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial -

Key Competitors in Japan for 2023 (E)

Table 44: Japan Recent Past, Current & Future Analysis for

Specialty Enzymes by Product - Protease, Carbohydrases,

Polymerases & Nucleases, Lipase and Other Products -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 45: Japan Historic Review for Specialty Enzymes by

Product - Protease, Carbohydrases, Polymerases & Nucleases,

Lipase and Other Products Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2014 through 2021 and %

CAGR

Table 46: Japan 16-Year Perspective for Specialty Enzymes by

Product - Percentage Breakdown of Value Sales for Protease,

Carbohydrases, Polymerases & Nucleases, Lipase and Other

Products for the Years 2014, 2023 & 2030

Table 47: Japan Recent Past, Current & Future Analysis for

Specialty Enzymes by Application - Pharmaceuticals, Research &

Biotechnology, Diagnostics and Other Applications - Independent

Analysis of Annual Sales in US$ Million for the Years 2022

through 2030 and % CAGR

Table 48: Japan Historic Review for Specialty Enzymes by

Application - Pharmaceuticals, Research & Biotechnology,

Diagnostics and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2014 through

2021 and % CAGR

Table 49: Japan 16-Year Perspective for Specialty Enzymes by

Application - Percentage Breakdown of Value Sales for

Pharmaceuticals, Research & Biotechnology, Diagnostics and

Other Applications for the Years 2014, 2023 & 2030

CHINA

Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial -

Key Competitors in China for 2023 (E)

Table 50: China Recent Past, Current & Future Analysis for

Specialty Enzymes by Product - Protease, Carbohydrases,

Polymerases & Nucleases, Lipase and Other Products -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 51: China Historic Review for Specialty Enzymes by

Product - Protease, Carbohydrases, Polymerases & Nucleases,

Lipase and Other Products Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2014 through 2021 and %

CAGR

Table 52: China 16-Year Perspective for Specialty Enzymes by

Product - Percentage Breakdown of Value Sales for Protease,

Carbohydrases, Polymerases & Nucleases, Lipase and Other

Products for the Years 2014, 2023 & 2030

Table 53: China Recent Past, Current & Future Analysis for

Specialty Enzymes by Application - Pharmaceuticals, Research &

Biotechnology, Diagnostics and Other Applications - Independent

Analysis of Annual Sales in US$ Million for the Years 2022

through 2030 and % CAGR

Table 54: China Historic Review for Specialty Enzymes by

Application - Pharmaceuticals, Research & Biotechnology,

Diagnostics and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2014 through

2021 and % CAGR

Table 55: China 16-Year Perspective for Specialty Enzymes by

Application - Percentage Breakdown of Value Sales for

Pharmaceuticals, Research & Biotechnology, Diagnostics and

Other Applications for the Years 2014, 2023 & 2030

EUROPE

Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial -

Key Competitors in Europe for 2023 (E)

Table 56: Europe Recent Past, Current & Future Analysis for

Specialty Enzymes by Geographic Region - France, Germany,

Italy, UK, Spain, Russia and Rest of Europe Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2022 through 2030 and % CAGR

Table 57: Europe Historic Review for Specialty Enzymes by

Geographic Region - France, Germany, Italy, UK, Spain, Russia

and Rest of Europe Markets - Independent Analysis of Annual

Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 58: Europe 16-Year Perspective for Specialty Enzymes by

Geographic Region - Percentage Breakdown of Value Sales for

France, Germany, Italy, UK, Spain, Russia and Rest of Europe

Markets for Years 2014, 2023 & 2030

Table 59: Europe Recent Past, Current & Future Analysis for

Specialty Enzymes by Product - Protease, Carbohydrases,

Polymerases & Nucleases, Lipase and Other Products -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 60: Europe Historic Review for Specialty Enzymes by

Product - Protease, Carbohydrases, Polymerases & Nucleases,

Lipase and Other Products Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2014 through 2021 and %

CAGR

Table 61: Europe 16-Year Perspective for Specialty Enzymes by

Product - Percentage Breakdown of Value Sales for Protease,

Carbohydrases, Polymerases & Nucleases, Lipase and Other

Products for the Years 2014, 2023 & 2030

Table 62: Europe Recent Past, Current & Future Analysis for

Specialty Enzymes by Application - Pharmaceuticals, Research &

Biotechnology, Diagnostics and Other Applications - Independent

Analysis of Annual Sales in US$ Million for the Years 2022

through 2030 and % CAGR

Table 63: Europe Historic Review for Specialty Enzymes by

Application - Pharmaceuticals, Research & Biotechnology,

Diagnostics and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2014 through

2021 and % CAGR

Table 64: Europe 16-Year Perspective for Specialty Enzymes by

Application - Percentage Breakdown of Value Sales for

Pharmaceuticals, Research & Biotechnology, Diagnostics and

Other Applications for the Years 2014, 2023 & 2030

FRANCE

Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial -

Key Competitors in France for 2023 (E)

Table 65: France Recent Past, Current & Future Analysis for

Specialty Enzymes by Product - Protease, Carbohydrases,

Polymerases & Nucleases, Lipase and Other Products -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 66: France Historic Review for Specialty Enzymes by

Product - Protease, Carbohydrases, Polymerases & Nucleases,

Lipase and Other Products Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2014 through 2021 and %

CAGR

Table 67: France 16-Year Perspective for Specialty Enzymes by

Product - Percentage Breakdown of Value Sales for Protease,

Carbohydrases, Polymerases & Nucleases, Lipase and Other

Products for the Years 2014, 2023 & 2030

Table 68: France Recent Past, Current & Future Analysis for

Specialty Enzymes by Application - Pharmaceuticals, Research &

Biotechnology, Diagnostics and Other Applications - Independent

Analysis of Annual Sales in US$ Million for the Years 2022

through 2030 and % CAGR

Table 69: France Historic Review for Specialty Enzymes by

Application - Pharmaceuticals, Research & Biotechnology,

Diagnostics and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2014 through

2021 and % CAGR

Table 70: France 16-Year Perspective for Specialty Enzymes by

Application - Percentage Breakdown of Value Sales for

Pharmaceuticals, Research & Biotechnology, Diagnostics and

Other Applications for the Years 2014, 2023 & 2030

GERMANY

Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial -

Key Competitors in Germany for 2023 (E)

Table 71: Germany Recent Past, Current & Future Analysis for

Specialty Enzymes by Product - Protease, Carbohydrases,

Polymerases & Nucleases, Lipase and Other Products -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 72: Germany Historic Review for Specialty Enzymes by

Product - Protease, Carbohydrases, Polymerases & Nucleases,

Lipase and Other Products Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2014 through 2021 and %

CAGR

Table 73: Germany 16-Year Perspective for Specialty Enzymes by

Product - Percentage Breakdown of Value Sales for Protease,

Carbohydrases, Polymerases & Nucleases, Lipase and Other

Products for the Years 2014, 2023 & 2030

Table 74: Germany Recent Past, Current & Future Analysis for

Specialty Enzymes by Application - Pharmaceuticals, Research &

Biotechnology, Diagnostics and Other Applications - Independent

Analysis of Annual Sales in US$ Million for the Years 2022

through 2030 and % CAGR

Table 75: Germany Historic Review for Specialty Enzymes by

Application - Pharmaceuticals, Research & Biotechnology,

Diagnostics and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2014 through

2021 and % CAGR

Table 76: Germany 16-Year Perspective for Specialty Enzymes by

Application - Percentage Breakdown of Value Sales for

Pharmaceuticals, Research & Biotechnology, Diagnostics and

Other Applications for the Years 2014, 2023 & 2030

ITALY

Table 77: Italy Recent Past, Current & Future Analysis for

Specialty Enzymes by Product - Protease, Carbohydrases,

Polymerases & Nucleases, Lipase and Other Products -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 78: Italy Historic Review for Specialty Enzymes by

Product - Protease, Carbohydrases, Polymerases & Nucleases,

Lipase and Other Products Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2014 through 2021 and %

CAGR

Table 79: Italy 16-Year Perspective for Specialty Enzymes by

Product - Percentage Breakdown of Value Sales for Protease,

Carbohydrases, Polymerases & Nucleases, Lipase and Other

Products for the Years 2014, 2023 & 2030

Table 80: Italy Recent Past, Current & Future Analysis for

Specialty Enzymes by Application - Pharmaceuticals, Research &

Biotechnology, Diagnostics and Other Applications - Independent

Analysis of Annual Sales in US$ Million for the Years 2022

through 2030 and % CAGR

Table 81: Italy Historic Review for Specialty Enzymes by

Application - Pharmaceuticals, Research & Biotechnology,

Diagnostics and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2014 through

2021 and % CAGR

Table 82: Italy 16-Year Perspective for Specialty Enzymes by

Application - Percentage Breakdown of Value Sales for

Pharmaceuticals, Research & Biotechnology, Diagnostics and

Other Applications for the Years 2014, 2023 & 2030

UNITED KINGDOM

Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial -

Key Competitors in the United Kingdom for 2023 (E)

Table 83: UK Recent Past, Current & Future Analysis for

Specialty Enzymes by Product - Protease, Carbohydrases,

Polymerases & Nucleases, Lipase and Other Products -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 84: UK Historic Review for Specialty Enzymes by Product -

Protease, Carbohydrases, Polymerases & Nucleases, Lipase and

Other Products Markets - Independent Analysis of Annual Sales

in US$ Million for Years 2014 through 2021 and % CAGR

Table 85: UK 16-Year Perspective for Specialty Enzymes by

Product - Percentage Breakdown of Value Sales for Protease,

Carbohydrases, Polymerases & Nucleases, Lipase and Other

Products for the Years 2014, 2023 & 2030

Table 86: UK Recent Past, Current & Future Analysis for

Specialty Enzymes by Application - Pharmaceuticals, Research &

Biotechnology, Diagnostics and Other Applications - Independent

Analysis of Annual Sales in US$ Million for the Years 2022

through 2030 and % CAGR

Table 87: UK Historic Review for Specialty Enzymes by

Application - Pharmaceuticals, Research & Biotechnology,

Diagnostics and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2014 through

2021 and % CAGR

Table 88: UK 16-Year Perspective for Specialty Enzymes by

Application - Percentage Breakdown of Value Sales for

Pharmaceuticals, Research & Biotechnology, Diagnostics and

Other Applications for the Years 2014, 2023 & 2030

SPAIN

Table 89: Spain Recent Past, Current & Future Analysis for

Specialty Enzymes by Product - Protease, Carbohydrases,

Polymerases & Nucleases, Lipase and Other Products -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 90: Spain Historic Review for Specialty Enzymes by

Product - Protease, Carbohydrases, Polymerases & Nucleases,

Lipase and Other Products Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2014 through 2021 and %

CAGR

Table 91: Spain 16-Year Perspective for Specialty Enzymes by

Product - Percentage Breakdown of Value Sales for Protease,

Carbohydrases, Polymerases & Nucleases, Lipase and Other

Products for the Years 2014, 2023 & 2030

Table 92: Spain Recent Past, Current & Future Analysis for

Specialty Enzymes by Application - Pharmaceuticals, Research &

Biotechnology, Diagnostics and Other Applications - Independent

Analysis of Annual Sales in US$ Million for the Years 2022

through 2030 and % CAGR

Table 93: Spain Historic Review for Specialty Enzymes by

Application - Pharmaceuticals, Research & Biotechnology,

Diagnostics and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2014 through

2021 and % CAGR

Table 94: Spain 16-Year Perspective for Specialty Enzymes by

Application - Percentage Breakdown of Value Sales for

Pharmaceuticals, Research & Biotechnology, Diagnostics and

Other Applications for the Years 2014, 2023 & 2030

RUSSIA

Table 95: Russia Recent Past, Current & Future Analysis for

Specialty Enzymes by Product - Protease, Carbohydrases,

Polymerases & Nucleases, Lipase and Other Products -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 96: Russia Historic Review for Specialty Enzymes by

Product - Protease, Carbohydrases, Polymerases & Nucleases,

Lipase and Other Products Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2014 through 2021 and %

CAGR

Table 97: Russia 16-Year Perspective for Specialty Enzymes by

Product - Percentage Breakdown of Value Sales for Protease,

Carbohydrases, Polymerases & Nucleases, Lipase and Other

Products for the Years 2014, 2023 & 2030

Table 98: Russia Recent Past, Current & Future Analysis for

Specialty Enzymes by Application - Pharmaceuticals, Research &

Biotechnology, Diagnostics and Other Applications - Independent

Analysis of Annual Sales in US$ Million for the Years 2022

through 2030 and % CAGR

Table 99: Russia Historic Review for Specialty Enzymes by

Application - Pharmaceuticals, Research & Biotechnology,

Diagnostics and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2014 through

2021 and % CAGR

Table 100: Russia 16-Year Perspective for Specialty Enzymes by

Application - Percentage Breakdown of Value Sales for

Pharmaceuticals, Research & Biotechnology, Diagnostics and

Other Applications for the Years 2014, 2023 & 2030

REST OF EUROPE

Table 101: Rest of Europe Recent Past, Current & Future

Analysis for Specialty Enzymes by Product - Protease,

Carbohydrases, Polymerases & Nucleases, Lipase and Other

Products - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 102: Rest of Europe Historic Review for Specialty Enzymes

by Product - Protease, Carbohydrases, Polymerases & Nucleases,

Lipase and Other Products Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2014 through 2021 and %

CAGR

Table 103: Rest of Europe 16-Year Perspective for Specialty

Enzymes by Product - Percentage Breakdown of Value Sales for

Protease, Carbohydrases, Polymerases & Nucleases, Lipase and

Other Products for the Years 2014, 2023 & 2030

Table 104: Rest of Europe Recent Past, Current & Future

Analysis for Specialty Enzymes by Application -

Pharmaceuticals, Research & Biotechnology, Diagnostics and

Other Applications - Independent Analysis of Annual Sales in

US$ Million for the Years 2022 through 2030 and % CAGR

Table 105: Rest of Europe Historic Review for Specialty Enzymes

by Application - Pharmaceuticals, Research & Biotechnology,

Diagnostics and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2014 through

2021 and % CAGR

Table 106: Rest of Europe 16-Year Perspective for Specialty

Enzymes by Application - Percentage Breakdown of Value Sales

for Pharmaceuticals, Research & Biotechnology, Diagnostics and

Other Applications for the Years 2014, 2023 & 2030

ASIA-PACIFIC

Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial -

Key Competitors in Asia-Pacific for 2023 (E)

Table 107: Asia-Pacific Recent Past, Current & Future Analysis

for Specialty Enzymes by Geographic Region - Australia, India,

South Korea and Rest of Asia-Pacific Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2022 through

2030 and % CAGR

Table 108: Asia-Pacific Historic Review for Specialty Enzymes

by Geographic Region - Australia, India, South Korea and Rest

of Asia-Pacific Markets - Independent Analysis of Annual Sales

in US$ Million for Years 2014 through 2021 and % CAGR

Table 109: Asia-Pacific 16-Year Perspective for Specialty

Enzymes by Geographic Region - Percentage Breakdown of Value

Sales for Australia, India, South Korea and Rest of

Asia-Pacific Markets for Years 2014, 2023 & 2030

Table 110: Asia-Pacific Recent Past, Current & Future Analysis

for Specialty Enzymes by Product - Protease, Carbohydrases,

Polymerases & Nucleases, Lipase and Other Products -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 111: Asia-Pacific Historic Review for Specialty Enzymes

by Product - Protease, Carbohydrases, Polymerases & Nucleases,

Lipase and Other Products Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2014 through 2021 and %

CAGR

Table 112: Asia-Pacific 16-Year Perspective for Specialty

Enzymes by Product - Percentage Breakdown of Value Sales for

Protease, Carbohydrases, Polymerases & Nucleases, Lipase and

Other Products for the Years 2014, 2023 & 2030

Table 113: Asia-Pacific Recent Past, Current & Future Analysis

for Specialty Enzymes by Application - Pharmaceuticals,

Research & Biotechnology, Diagnostics and Other Applications -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 114: Asia-Pacific Historic Review for Specialty Enzymes

by Application - Pharmaceuticals, Research & Biotechnology,

Diagnostics and Other Applications Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2014 through

2021 and % CAGR

Table 115: Asia-Pacific 16-Year Perspective for Specialty

Enzymes by Application - Percentage Breakdown of Value Sales

for Pharmaceuticals, Research & Biotechnology, Diagnostics and

Other Applications for the Years 2014, 2023 & 2030

AUSTRALIA

Specialty Enzymes Market Presence - Strong/Active/Niche/Trivial -

Key Competitors in Australia for 2023 (E)

Table 116: Australia Recent Past, Current & Future Analysis for

Specialty Enzymes by Product - Protease, Carbohydrases,

Polymerases & Nucleases, Lipase and Other Products -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 117: Australia Historic Review for Specialty Enzymes by

Product - Protease, Carbohydrases, Polymerases & Nucleases,

Lipase and Other Products Markets - Independent Analysis of

Please contact our Customer Support Center to get the complete Table of Contents

Read the full report: https://www.reportlinker.com/p090599/?utm_source=PRN

About Reportlinker

ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Contact Clare: clare@reportlinker.com

US: (339)-368-6001

Intl: +1 339-368-6001

View original content to download multimedia:https://www.prnewswire.com/news-releases/global-specialty-enzymes-market-to-reach-13-6-billion-by-2030--301749113.html

SOURCE Reportlinker